Literature DB >> 23182134

Addressing the bottleneck at clinical testing of candidate malaria vaccines.

Denise L Doolan1, Simon H Apte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23182134      PMCID： PMC4005128          DOI： 10.1179/2047772412Z.00000000081

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN： 2047-7724            Impact factor:   2.894


× No keyword cloud information.
  8 in total

1.  First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

Authors:  Selidji Todagbe Agnandji; Bertrand Lell; Solange Solmeheim Soulanoudjingar; José Francisco Fernandes; Béatrice Peggy Abossolo; Cornelia Conzelmann; Barbara Gaelle Nfono Ondo Methogo; Yannick Doucka; Arnaud Flamen; Benjamin Mordmüller; Saadou Issifou; Peter Gottfried Kremsner; Jahit Sacarlal; Pedro Aide; Miguel Lanaspa; John J Aponte; Arlindo Nhamuave; Diana Quelhas; Quique Bassat; Sofia Mandjate; Eusébio Macete; Pedro Alonso; Salim Abdulla; Nahya Salim; Omar Juma; Mwanajaa Shomari; Kafuruki Shubis; Francisca Machera; Ali Said Hamad; Rose Minja; Ali Mtoro; Alma Sykes; Saumu Ahmed; Alwisa Martin Urassa; Ali Mohammed Ali; Grace Mwangoka; Marcel Tanner; Halidou Tinto; Umberto D'Alessandro; Hermann Sorgho; Innocent Valea; Marc Christian Tahita; William Kaboré; Sayouba Ouédraogo; Yara Sandrine; Robert Tinga Guiguemdé; Jean Bosco Ouédraogo; Mary J Hamel; Simon Kariuki; Chris Odero; Martina Oneko; Kephas Otieno; Norbert Awino; Jackton Omoto; John Williamson; Vincent Muturi-Kioi; Kayla F Laserson; Laurence Slutsker; Walter Otieno; Lucas Otieno; Otsyula Nekoye; Stacey Gondi; Allan Otieno; Bernhards Ogutu; Ruth Wasuna; Victorine Owira; David Jones; Agnes Akoth Onyango; Patricia Njuguna; Roma Chilengi; Pauline Akoo; Christine Kerubo; Jesse Gitaka; Charity Maingi; Trudie Lang; Ally Olotu; Benjamin Tsofa; Philip Bejon; Norbert Peshu; Kevin Marsh; Seth Owusu-Agyei; Kwaku Poku Asante; Kingsley Osei-Kwakye; Owusu Boahen; Samuel Ayamba; Kingsley Kayan; Ruth Owusu-Ofori; David Dosoo; Isaac Asante; George Adjei; George Adjei; Daniel Chandramohan; Brian Greenwood; John Lusingu; Samwel Gesase; Anangisye Malabeja; Omari Abdul; Hassan Kilavo; Coline Mahende; Edwin Liheluka; Martha Lemnge; Thor Theander; Chris Drakeley; Daniel Ansong; Tsiri Agbenyega; Samuel Adjei; Harry Owusu Boateng; Theresa Rettig; John Bawa; Justice Sylverken; David Sambian; Alex Agyekum; Larko Owusu; Francis Martinson; Irving Hoffman; Tisungane Mvalo; Portia Kamthunzi; Ruthendo Nkomo; Albans Msika; Allan Jumbe; Nelecy Chome; Dalitso Nyakuipa; Joseph Chintedza; W Ripley Ballou; Myriam Bruls; Joe Cohen; Yolanda Guerra; Erik Jongert; Didier Lapierre; Amanda Leach; Marc Lievens; Opokua Ofori-Anyinam; Johan Vekemans; Terrell Carter; Didier Leboulleux; Christian Loucq; Afiya Radford; Barbara Savarese; David Schellenberg; Marla Sillman; Preeti Vansadia
Journal:  N Engl J Med       Date:  2011-10-18       Impact factor: 91.245

2.  Efficacy of preerythrocytic and blood-stage malaria vaccines can be assessed in small sporozoite challenge trials in human volunteers.

Authors:  Meta Roestenberg; Sake J de Vlas; An-Emmie Nieman; Robert W Sauerwein; Cornelus C Hermsen
Journal:  J Infect Dis       Date:  2012-05-21       Impact factor: 5.226

3.  Malaria sporozoite challenge model comes of age.

Authors:  José A Stoute
Journal:  Pathog Glob Health       Date:  2012-10       Impact factor: 2.894

4.  A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccines.

Authors:  Matthew B Laurens; Christopher J Duncan; Judith E Epstein; Adrian V Hill; Jack L Komisar; Kirsten E Lyke; Christian F Ockenhouse; Thomas L Richie; Meta Roestenberg; Robert W Sauerwein; Michele D Spring; Angela K Talley; Vasee S Moorthy
Journal:  Vaccine       Date:  2012-05-31       Impact factor: 3.641

Review 5.  Malaria sporozoite: migrating for a living.

Authors:  Olivier Silvie; Jean-François Franetich; Luarent Rénia; Dominique Mazier
Journal:  Trends Mol Med       Date:  2004-03       Impact factor: 11.951

6.  Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA.

Authors:  V S Moorthy; C Diggs; S Ferro; M F Good; S Herrera; A V Hill; E B Imoukhuede; S Kumar; C Loucq; K Marsh; C F Ockenhouse; T L Richie; R W Sauerwein
Journal:  Vaccine       Date:  2009-08-03       Impact factor: 3.641

7.  Comparison of clinical and parasitological data from controlled human malaria infection trials.

Authors:  Meta Roestenberg; Geraldine A O'Hara; Christopher J A Duncan; Judith E Epstein; Nick J Edwards; Anja Scholzen; André J A M van der Ven; Cornelus C Hermsen; Adrian V S Hill; Robert W Sauerwein
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

8.  Allelic forms of gp195, a major blood-stage antigen of Plasmodium falciparum, are expressed in liver stages.

Authors:  A Szarfman; D Walliker; J S McBride; J A Lyon; I A Quakyi; R Carter
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307
  8 in total
  1 in total

1.  Malaria sporozoite challenge model comes of age.

Authors:  José A Stoute
Journal:  Pathog Glob Health       Date:  2012-10       Impact factor: 2.894
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.